Article
Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.
Clinical lung cancer - 1 Sept 2015
Qian Ji, Liu Hongliang, Gu Shaohua, Wu Qihan, Zhao Xueying, Wu Wenting, Wang Haijian, Wang Jiucun, Chen Hongyan, Zhang Wei, Wei Qingyi, Jin Li, Lu Daru
Abstract excerpt
INTRODUCTION: Platinum agents can cause the formation of DNA adducts and induce apoptosis to eliminate tumor cells. The aim of the present study was to investigate the influence of genetic variants of MDM2 on chemotherapy-related toxicities and clinical outcomes in patients with advanced non-smal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
